Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15092)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Aerts M, Benteyn D, Van Vlierberghe H, Thielemans K, Reynaert H. Current status and perspectives of immune-based therapies for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 253-261 [PMID: PMC4698490 DOI: 10.3748/wjg.v22.i1.253] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/253.htm |
| Number | Citing Articles |
| 1 |
Joseph P. Erinjeri, Gabriel C. Fine, Gosse J. Adema, Muneeb Ahmed, Julius Chapiro, Martijn den Brok, Rafael Duran, Stephen J. Hunt, D. Thor Johnson, Jens Ricke, Daniel Y. Sze, Beau Bosko Toskich, Bradford J. Wood, David Woodrum, S. Nahum Goldberg. Immunotherapy and the Interventional Oncologist: Challenges and Opportunities—A Society of Interventional Oncology White Paper. Radiology 2019; 292(1): 25 doi: 10.1148/radiol.2019182326
|
| 2 |
Min Ding, Ying Wang, Jiachang Chi, Tao Wang, Xiaoyin Tang, Dan Cui, Qijun Qian, Bo Zhai, Beicheng Sun. Is Adjuvant Cellular Immunotherapy Essential after TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma? A Systematic Meta-Analysis of Studies Including 1774 Patients. PLOS ONE 2016; 11(12): e0168798 doi: 10.1371/journal.pone.0168798
|
| 3 |
David Stillström, Marie Beermann, Jennie Engstrand, Jacob Freedman, Henrik Nilsson. Initial experience with irreversible electroporation of liver tumours. European Journal of Radiology Open 2019; 6: 62 doi: 10.1016/j.ejro.2019.01.004
|
| 4 |
Zhichao Li, Guoliang Xue, Zhigang Wei, Xin Ye. Experimental study on the induction of cytotoxic T lymphocyte killing effects and dendritic-cell-based tumor vaccine prepared by high-intensity focused ultrasound. Journal of Cancer Research and Therapeutics 2022; 18(5): 1292 doi: 10.4103/jcrt.jcrt_2291_21
|
| 5 |
Xiaojing Ren, Yuanyuan Ji, Xuhua Jiang, Xun Qi. Down-regulation of siglec-2 (CD22) predicts worse overall survival from HBV-related early-stage hepatocellular carcinoma: a preliminary analysis from Gene Expression Omnibus. Bioscience Reports 2018; 38(6) doi: 10.1042/BSR20181423
|
| 6 |
Jasmine Sinha, Neil Mehta, Jennifer L. Dodge, Eduard Poltavskiy, John Roberts, Francis Yao. Are There Upper Limits in Tumor Burden for Down‐Staging of Hepatocellular Carcinoma to Liver Transplant? Analysis of the All‐Comers Protocol. Hepatology 2019; 70(4): 1185 doi: 10.1002/hep.30570
|
| 7 |
Valentina Arrè, Roberto Negro, Gianluigi Giannelli. The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights. Annals of Hepatology 2025; 30(1): 101772 doi: 10.1016/j.aohep.2024.101772
|
| 8 |
Chinthalapally V. Rao, Adam S. Asch, Hiroshi Y. Yamada. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancer. Carcinogenesis 2017; 38(1): 2 doi: 10.1093/carcin/bgw118
|
| 9 |
Rui Han, Yuqian Wang, Lingeng Lu. Sensitizing the Efficiency of ICIs by Neoantigen mRNA Vaccines for HCC Treatment. Pharmaceutics 2023; 16(1): 59 doi: 10.3390/pharmaceutics16010059
|
| 10 |
Chenwei Pan, Luxia Xiang, Zhenzhen Pan, Xiaodong Wang, Jie Li, Lu Zhuge, Peipei Fang, Qipeng Xie, Xuezhen Hu. MiR-544 promotes immune escape through downregulation of NCR1/NKp46 via targeting RUNX3 in liver cancer. Cancer Cell International 2018; 18(1) doi: 10.1186/s12935-018-0542-y
|
| 11 |
Dimitrios N Samonakis, Elias A Kouroumalis. Systemic treatment for hepatocellular carcinoma: Still unmet expectations. World Journal of Hepatology 2017; 9(2): 80-90 doi: 10.4254/wjh.v9.i2.80
|
| 12 |
Yang Chen, Chang-Yong E, Zhi-Wen Gong, Shui Liu, Zhen-Xiao Wang, Yong-Sheng Yang, Xue-Wen Zhang. Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Hepatobiliary & Pancreatic Diseases International 2018; 17(4): 301 doi: 10.1016/j.hbpd.2018.05.005
|
| 13 |
V. V. Breder, M. U. Pitkevich, E. R. Virshke, L. A. Kostyakova, I. A. Dzhanyan, K. K. Laktionov. BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started. Medical Council 2018; (10): 27 doi: 10.21518/2079-701X-2018-10-27-32
|
| 14 |
Hongchi Yu, Yang Shen, Jingsi Jin, Yingying Zhang, Tang Feng, Xiaoheng Liu. Fluid shear stress regulates HepG2 cell migration though time-dependent integrin signaling cascade. Cell Adhesion & Migration 2018; 12(1): 56 doi: 10.1080/19336918.2017.1319042
|
| 15 |
Mostafa MM El-Miligy, Samia M Rida, Fawzia A Ashour, Mona H Badr, Ehab M El-Bassiony, Maha A El-Demellawy, Ashraf M Omar. Dual Inhibitors of Hepatitis C Virus and Hepatocellular Carcinoma: Design, Synthesis and Docking Studies. Future Science OA 2018; 4(1) doi: 10.4155/fsoa-2017-0075
|
| 16 |
David Stillström, Benjamin Eigl, Jacob Freedman. Stereotactic navigation versus ultrasound guidance in placing IRE applicators in a liver phantom. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00505-1
|
| 17 |
K. Okrah, S. Tarighat, B. Liu, H. Koeppen, M. C. Wagle, G. Cheng, C. Sun, A. Dey, M. T. Chang, T. Sumiyoshi, Z. Mounir, C. Cummings, G. Hampton, L. Amler, J. Fridlyand, P. S. Hegde, S. J. Turley, M. R. Lackner, S. M. Huang. Transcriptomic analysis of hepatocellular carcinoma reveals molecular features of disease progression and tumor immune biology. npj Precision Oncology 2018; 2(1) doi: 10.1038/s41698-018-0068-8
|
| 18 |
Baohui Zhang, Bufu Tang, Jiarui Lv, Jianyao Gao, Ling Qin. Systematic analyses to explore immune gene sets-based signature in hepatocellular carcinoma, in which IGF2BP3 contributes to tumor progression. Clinical Immunology 2022; 241: 109073 doi: 10.1016/j.clim.2022.109073
|
| 19 |
Qing Zhang, Xiang‐Fei Yuan, Yang Lu, Zhen‐Zhen Li, Shi‐Qi Bao, Xiao‐Long Zhang, Yuan‐Yuan Yang, Dong‐Mei Fan, Yi‐Zhi Zhang, Chen‐Xuan Wu, Hong‐Xing Guo, Yan‐Jun Zhang, Zhou Ye, Dong‐Sheng Xiong. Surface expression of anti‐CD3scfv stimulates locoregional immunotherapy against hepatocellular carcinoma depending on the E1A‐engineered human umbilical cord mesenchymal stem cells. International Journal of Cancer 2017; 141(7): 1445 doi: 10.1002/ijc.30846
|
| 20 |
Francesco Paolo Russo, Angela Imondi, Erica Nicola Lynch, Fabio Farinati. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. Digestive and Liver Disease 2018; 50(7): 640 doi: 10.1016/j.dld.2018.03.014
|
| 21 |
Samantha A. Armstrong, Aiwu Ruth He. Immuno-oncology for Hepatocellular Carcinoma. Clinics in Liver Disease 2020; 24(4): 739 doi: 10.1016/j.cld.2020.07.007
|
| 22 |
Katharina Leuchte, Elena Staib, Martin Thelen, Philipp Gödel, Axel Lechner, Peter Zentis, Maria Garcia-Marquez, Dirk Waldschmidt, Rabi Raj Datta, Roger Wahba, Christian Wybranski, Thomas Zander, Alexander Quaas, Uta Drebber, Dirk Ludger Stippel, Christiane Bruns, Michael von Bergwelt-Baildon, Kerstin Wennhold, Hans Anton Schlößer. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2021; 70(4): 893 doi: 10.1007/s00262-020-02734-1
|
| 23 |
Kangwei Wang, Xin Nie, Zhuona Rong, Tingting Fan, Juan Li, Xinxin Wang, Huiling Li, Jianyi Dong, Jun Chen, Fujin Wang, Jingyu Wang, Aiguo Wang. B lymphocytes repress hepatic tumorigenesis but not development in Hras12V transgenic mice. International Journal of Cancer 2017; 141(6): 1201 doi: 10.1002/ijc.30823
|
| 24 |
Yen‐Hao Erik Lai, Robert Morhard, Nirmala Ramanujam, Michael W. Nolan. Minimally invasive ethyl cellulose ethanol ablation in domesticated cats with naturally occurring head and neck cancers: Six cats. Veterinary and Comparative Oncology 2021; 19(3): 492 doi: 10.1111/vco.12687
|
| 25 |
Josefa A. Rodríguez. HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activation. Oncology Letters 2017; 14(4): 4415 doi: 10.3892/ol.2017.6784
|
| 26 |
Jong Man Kim, Sung Yoo Cho, Jinsoo Rhu, Miyoung Jung, Jung Hyun Her, Okjae Lim, Gyu-Seong Choi, Eui-Cheol Shin, Yu-Kyeong Hwang, Jae-Won Joh. Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study. Annals of Hepato-Biliary-Pancreatic Surgery 2021; 25(2): 206 doi: 10.14701/ahbps.2021.25.2.206
|
| 27 |
Vito Longo, Antonio Gnoni, Andrea Casadei Gardini, Salvatore Pisconti, Antonella Licchetta, Mario Scartozzi, Riccardo Memeo, Vincenzo Ostilio Palmieri, Giuseppe Aprile, Daniele Santini, Patrizia Nardulli, Nicola Silvestris, Oronzo Brunetti. Immunotherapeutic approaches for hepatocellular carcinoma. Oncotarget 2017; 8(20): 33897 doi: 10.18632/oncotarget.15406
|
| 28 |
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma. PeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
|
| 29 |
J. Mittler, H. Lang. Entwicklungen der Immunmodulation nach Transplantation im Hinblick auf De-novo-Malignome und Tumorrezidive. Der Onkologe 2016; 22(7): 461 doi: 10.1007/s00761-016-0051-3
|
| 30 |
Hendrik Reynaert, Isabelle Colle. Treatment of Advanced Hepatocellular Carcinoma with Somatostatin Analogues: A Review of the Literature. International Journal of Molecular Sciences 2019; 20(19): 4811 doi: 10.3390/ijms20194811
|
| 31 |
Ruwanthi Kolamunnage-Dona, Adina Najwa Kamarudin. Adjustment for the measurement error in evaluating biomarker performances at baseline for future survival outcomes: Time-dependent receiver operating characteristic curve within a joint modelling framework. Research Methods in Medicine & Health Sciences 2021; 2(2): 51 doi: 10.1177/2632084320972257
|
| 32 |
David Stillström, Raluca-Maria Sandu, Jacob Freedman. Accuracy of Electrode Placement in IRE Treatment with Navigated Guidance. CardioVascular and Interventional Radiology 2021; 44(6): 968 doi: 10.1007/s00270-020-02762-5
|
| 33 |
Jian-Wang Li, Chun-Zhen Huang, Jian-Hua Li, Jian-Hua Yuan, Qiong-Hui Chen, Wei-Fang Zhang, Zhen-Sheng Xu, Ying-Ping Liu, Yong Li, Mei-Xiao Zhan, Li-Gong Lu. Six2 is negatively correlated with good prognosis and decreases 5-FU sensitivity via suppressing E-cadherin expression in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2018; 104: 204 doi: 10.1016/j.biopha.2018.05.032
|